欧州前立腺がん診断市場
Market Size in USD Billion
CAGR :
% 
 予測期間 |
2021 –2028 |
 市場規模（基準年） |
USD 636.30 Million |
 Market Size (Forecast Year) |
USD 1,604.78 Million |
 CAGR |
% |
| 主要市場プレーヤー |
ヨーロッパの前立腺がん診断薬市場、製品タイプ別（機器、試薬、消耗品、付属品）、診断タイプ別（予備スクリーニング検査、確認検査）、年齢層別（成人、小児、老年）、タイプ別（前立腺腺がん、小細胞がん、その他）、ステージ別（局所性前立腺がん、再発性/進行性前立腺がん、去勢抵抗性前立腺がん（転移性および非転移性）、サンプルタイプ別（血液、組織、尿、その他）、エンドユーザー別（独立診断研究所、病院、がん研究機関、診療所、外来手術センター、その他）、流通チャネル別（直接入札および小売販売）、国別（ドイツ、フランス、英国、イタリア、スペイン、ロシア、トルコ、オランダ、スイス、ベルギー、その他のヨーロッパ諸国）2028年までの業界動向と予測
市場分析と洞察: ヨーロッパの前立腺がん診断市場
前立腺がん診断市場は、2021年から2028年の予測期間に市場成長を遂げると予想されています。データブリッジマーケットリサーチは、市場は2021年から2028年の予測期間に12.5％のCAGRで成長し、2020年の6億3,630万米ドルから2028年には16億478万米ドルに達すると分析しています。疾患負担への注目の高まりと疾患に関する意識の高まりは、予測期間に市場を推進する主な原動力です。
診断には、器具、試薬、消耗品、付属品が使用されます。PSA検査、デジタル直腸検査、MRI、PET/CTスキャンなどは、前立腺がんの診断に使用される予備検査および確認検査の一部です。前立腺がんの罹患率の増加、前立腺がん診断の研究開発の増加、高齢者人口の増加、前立腺がん診断の新製品の発売は、前立腺がん診断市場の成長を促進すると予想されます。さらに、新興企業による投資と資金の増加、前立腺がん診断の償還ポリシー、がん診断に向けた政府の取り組みは、前立腺がん診断市場の成長を後押しします。
前立腺がんの診断に対する需要は先進国と発展途上国の両方で増加しており、その背景にあるのは前立腺がんの死亡率に対する注目が高まっていることです。前立腺がんの診断市場は、革新的な製品の導入、意識の高まり、さまざまな政府の取り組みにより成長しています。市場は、新興市場の探索、市場関係者による戦略的取り組み、髪の問題に関する意識の高まりにより、予測期間中に成長するでしょう。
The prostate cancer diagnostics market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.
Europe Prostate Cancer Diagnostics Market Scope and Market Size
The prostate cancer diagnostics market is categorized into eight notable segments which are based on the product type, diagnostics type, age group, type, stage, sample type, end users and distribution channel.
- On the basis of product type, the prostate cancer diagnostics market is segmented into instruments, reagents & consumables and accessories. In 2021, reagents & consumables segment is dominating in the prostate cancer diagnostics market as it includes the PSA testing products which is the primary test recommended for preliminary testing. PSA measures protein made by cells in prostate gland which is the first line of diagnosis for prostate cancer.
- On the basis of diagnostics type, the prostate cancer diagnostics market is segmented into preliminary screening tests and confirmatory tests. In 2021, preliminary screening tests segment is dominating in the prostate cancer diagnostics market as the number of preliminary tests surpass the number of confirmatory tests by significant percentage.
- On the basis of age group, the prostate cancer diagnostics market is segmented into adult, pediatric and geriatrics. In 2021, geriatrics segment is dominating in the prostate cancer diagnostics market as around 60% of cases are diagnosed in men over 65 year of age. The average age of prostate cancer diagnostics is 66 years. The disease rarely occurs in those younger than 40. The number of new cases diagnosed in black men is 60% higher than to the number of new cases diagnosed in white men.
- On the basis of type, the prostate cancer diagnostics market is segmented into prostatic adenocarcinoma, small cell carcinoma and others. In 2021, prostatic adenocarcinoma segment dominates the prostate cancer diagnostics market because more than 95 percent of prostate cancers are adenocarcinomas which develop in the gland cells and line of the prostate gland. Nearly, all the men with prostate cancer have this type. It is the second leading cause of cancer-related death in men. Once the cancer reaches a certain stage, then the abnormal cells spread to other parts of the body, hence causing metastasis which leads to dominating the segment of the market.
- ステージに基づいて、前立腺がんの診断市場は、局所性前立腺がん、再発性/進行性前立腺がん、去勢抵抗性前立腺がん（転移性および非転移性）に分類されます。 2021年には、すべての前立腺がんの約80％から85％がステージI、II、IIIを表す局所または地域段階で検出されるため、局所性前立腺がんセグメントが前立腺がん診断市場を支配します。 局所または地域段階で診断され治療を受けた男性のほとんどは、5年後には病気がなくなります。 このタイプのがんは、近くの組織や体の離れた部分に広がることはありません。 局所性前立腺がんのステージはステージ1と2です。 低リスクの局所性前立腺がんの腫瘍の成長は遅いです。
- サンプルの種類に基づいて、前立腺がん診断市場は、血液、組織、尿、その他に分類されます。2021年には、血液セグメントが前立腺がん診断市場を支配します。これは、血液が最も一般的な予備検査であるPSA検査の主なサンプルであり、血液の入手が容易なため、血液サンプルの収集手順がそれほど複雑ではなく、時間がかからないため、前立腺がん診断市場を支配すると予想されます。
- エンドユーザーに基づいて、前立腺がん診断市場は、独立した診断研究所、病院、がん研究機関、診療所、外来手術センターなどに分類されます。2021年には、独立した診断研究所セグメントが前立腺がん診断市場を支配しています。このセグメントは、さまざまな前立腺がん診断の実施に特化しているためです。さらに、独立した診断研究所は、安全な医療環境で堅牢で時間どおりに、費用対効果が高く、高品質の診断ケアとサービスを促進することを可能にし、より良い顧客サービスのために医師/医療機関が独立した診断研究所に大量の診断テストを外注するのに便利です。
- 流通タイプに基づいて、前立腺がん診断市場は、直接入札と小売販売に分割されています。 2021年には、直接入札セグメントが前立腺がん診断市場を支配します。これは、医療機関や診断ラボによる試薬、消耗品、デバイス、アクセサリの調達の主なソースであるためです。 医療費の増加に伴い、医療サービスプロバイダーは、全体的なコストを削減するとともに、顧客へのより良いサービスに注力しています。 直接入札による製品の調達は、医療提供者にとって非常に費用対効果が高くなります。
前立腺がん診断市場の国別分析
前立腺がん診断市場は、製品タイプ、診断タイプ、年齢層、タイプ、ステージ、サンプルタイプ、エンドユーザー、流通チャネルに基づいて、8 つの主要なセグメントに分類されます。
前立腺がん診断市場レポートで取り上げられている国は、ドイツ、フランス、英国、イタリア、スペイン、ロシア、トルコ、オランダ、スイス、ベルギー、その他のヨーロッパ諸国です。
ヨーロッパは、前立腺がんの罹患率の増加と有利な償還環境により、予測期間中に最高の CAGR で成長すると予想されています。主に高齢者人口の増加により、ドイツがヨーロッパ市場で優位に立つと予想されています。
レポートの国別セクションでは、市場の現在および将来の傾向に影響を与える国内市場における個別の市場影響要因と規制の変更も提供しています。新規販売、交換販売、国の人口統計、規制行為、輸出入関税などのデータ ポイントは、各国の市場シナリオを予測するために使用される主要な指標の一部です。また、国別データの予測分析を提供する際には、グローバル ブランドの存在と可用性、および地元および国内ブランドとの競争が激しいか少ないために直面する課題、販売チャネルの影響も考慮されます。
メーカーによる戦略的取り組みが前立腺がん診断市場のプレーヤーに新たな機会を生み出している
前立腺がん診断市場では、各国の前立腺がん診断製品の売上成長、前立腺がん診断の進歩の影響、前立腺がん診断市場へのサポートに関する規制シナリオの変化など、詳細な市場分析も提供しています。データは、2011年から2019年までの履歴期間について入手できます。
競争環境と前立腺がん診断市場シェア分析
前立腺がん診断市場の競争状況は、競合他社ごとに詳細を提供します。含まれる詳細には、会社概要、会社の財務状況、収益、市場の可能性、研究開発への投資、新しい市場への取り組み、生産拠点と施設、会社の強みと弱み、製品の発売、製品試験パイプライン、製品の承認、特許、製品の幅と幅、アプリケーションの優位性、技術ライフライン曲線などがあります。提供されている上記のデータ ポイントは、前立腺がん診断市場に関連する会社の焦点にのみ関連しています。
前立腺がんの診断を提供する主な企業としては、F. Hoffmann-La Roche Ltd、Siemens Healthcare GmbH、OPKO Health Inc.、Abott、Beckman Coulter, Inc. (Danaher の子会社) など、国内外の企業が挙げられます。DBMR のアナリストは、競争上の強みを理解し、各競合他社の競合分析を個別に提供します。
世界中の企業によって多くの製品の発売や契約も開始されており、前立腺がん診断市場の成長も加速しています。
例えば、
- 2020年12月、富士レビオヨーロッパは、第三世代シーケンシング（TGS）技術を組み込んだ臨床体外診断（IVD）プラットフォームの開発のために、フランダースイノベーション＆アントレプレナーシップ（VLAIO）から総額87万6千米ドルの助成金を受けたと発表しました。これは、コスト効率が高く、正確でポータブルなIVDを開発するためのものです。これにより、会社のプロフィールが向上し、研究開発が促進されます。
市場プレーヤーによるコラボレーション、ジョイントベンチャー、その他の戦略により、前立腺がん診断市場における企業市場が強化され、組織にとっても前立腺がん診断市場への提供を改善するメリットがもたらされます。
SKU-
世界初のマーケットインテリジェンスクラウドに関するレポートにオンラインでアクセスする
- インタラクティブなデータ分析ダッシュボード
- 成長の可能性が高い機会のための企業分析ダッシュボード
- カスタマイズとクエリのためのリサーチアナリストアクセス
- インタラクティブなダッシュボードによる競合分析
- 最新ニュース、更新情報、トレンド分析
- 包括的な競合追跡のためのベンチマーク分析のパワーを活用
目次
- introduction
- OBJECTIVES OF THE STUDY
- MARKET DEFINITION
- OVERVIEW of EUROPE PROSTATE CANCER DIAGNOSTICS MARKET
- LIMITATIONs
- MARKETS COVERED
- MARKET SEGMENTATION
- MARKETS COVERED
- geographical scope
- years considered for the study
- currency and pricing
- DBMR TRIPOD DATA VALIDATION MODEL
- MULTIVARIATE MODELLING
- product type LIFELINE CURVE
- primary interviews with key opinion leaders
- DBMR MARKET POSITION GRID
- MARKET end users coverage GRID
- vendor share analysis
- secondary sourcEs
- assumptions
- EXECUTIVE SUMMARY
- Epidemiology
- COMPARATIVE ANALYSIS WITH PARENT MARKET
- REGULATORY FRAMEWORK: EUROPE PROSTATE CANCER DIAGNOSTICS MARKET
- REGULATORY SCENARIO IN EUROPEAN UNION
- market overview
- drivers
- INCREASING PREVALENCE OF PROSTATE CANCER
- INCREASE RESEARCH & DEVELOPMENT IN PROSTATE CANCER DIAGNOSTIC
- INCREASE IN GERIATRIC POPULATION
- LAUNCH OF NEW PRODUCTS FOR PROSTATE CANCER DIAGNOSTIC
- DISEASE CAUSING PROSTATE CANCER
- RESTRAINTS
- CONTROVERSY RELATED TO PSA TESTING
- HIGH COST OF DIAGNOSTICS PROCEDURE
- LACK OF SKILLED AND CERTIFIED PROFESSIONALS
- OPPORTUNITIES
- RISING INVESTMENT AND FUNDING BY EMERGING PLAYERS
- REIMBURSEMENT POLICY FOR PROSTATE CANCER DIAGNOSIS
- GOVERNMENT INITIATIVES TOWARDS CANCER DIAGNOSTICS
- RISING SURVIVAL RATE DUE TO EARLY DIAGNOSIS OF PROSTATE CANCER
- Challenges
- STRINGENT REGULATORY REQUIREMENT FOR DIAGNOSTIC PRODUCTS
- OPERATIONAL BARRIERS FACED IN CONDUCTING DIAGNOSTICS TESTS
- INACCURATE DIAGNOSIS RESULTS
- IMPACT OF COVID-19 ON EUROPE PROSTATE CANCER DIAGNOSTICS MARKET
- IMPACT ON PRICE
- IMPACT ON DEMAND
- IMPACT ON SUPPLY CHAIN
- STRATEGIC DECISION BY MANUFACTURERS MADE DURING COVID-19 PANDEMIC
- KEY INITIATIVES BY MARKET PLAYERS DURING COVID-19
- CONCLUSION
- Europe prostate cancer diagnostics market, BY product type
- overview
- reagents & consumables
- instruments
- accessories
- Europe prostate cancer diagnostics market, BY DIAGNOSTICS TYPE
- overview
- preliminary screening tests
- Prostate-Specific Antigen (PSA) Test
- Digital Rectal Exam (DRE) Test
- Confirmatory Tests
- PCA3 Test
- biopsy
- imaging tests
- ULTRASOUND
- MAGNETIC RESONANCE IMAGING (MRI)
- MULTIPARAMETRIC MRI
- MRI FUSION-GUIDED PROSTATE BIOPSY
- CT SCAN
- BONE SCAN
- PET/CT SCAN
- biomarker
- RNA BIOMARKERS
- DNA BIOMARKERS
- PROTEIN BIOMARKERS
- Europe prostate cancer diagnostics market, By type
- overview
- PROSTATIC ADENOCARCINOMA
- small cell carcinoma
- Others
- Europe prostate cancer diagnostics market, BY AGE GROUP
- overview
- geriatrics
- adult
- Pediatric
- Europe prostate cancer diagnostics market, BY Stage
- overview
- LOCALIZED PROSTATE CANCER
- RECURRENT/ADVANCED PROSTATE CANCER
- CASTRATION-RESISTANT PROSTATE CANCER (METASTATIC AND NON-METASTATIC)
- Europe prostate cancer diagnostics market, BY sample type
- overview
- Blood
- tissue
- urine
- others
- Europe prostate cancer diagnostics market, BY end users
- overview
- Independent Diagnostic Laboratories
- hospitals
- Clinics
- Ambulatory Surgical Centers
- Cancer Research Institutes
- others
- Europe prostate cancer diagnostics market, BY Distribution Channel
- overview
- direct tender
- retail sales
- Europe prostate cancer diagnostics market, BY Country
- GERMANY
- FRANCE
- u.k.
- iTALY
- SPAIN
- RUSSIA
- SWITZERLAND
- NETHERLANDS
- TURKEY
- bELGIUM
- REST OF EUROPE
- EUROPE PROSTATE CANCER DIAGNOSTICS MARKET: COMPANY landscape
- company share analysis: europe
- SWOT
- company profile
- F. Hoffmann-La Roche Ltd
- COMPANY SNAPSHot
- REVENUE ANALYSIS
- product Portfoli0
- RECENT DEVELOPMENTs
- Abbott
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- siemens HEALTHCARE gmbh
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- OPko HEALTH INC.
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- Beckman Coulter, Inc. (A Subsidiary of Danaher)
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- acon laboratories inc.
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- Biomerieux sa
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- Diasorin s.p.a
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLI0
- RECENT DEVELOPMENTS
- Eurolyser Diagnostica GmbH
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- FUJIREBIO
- COMPANY SNAPSHOT
- PRODUCT PORTFOLI
- RECENT DEVELOPMENTS
- GENOMIC HEALTH, INC., (A SUBSIDIARY OF EXACT SCIENCES CORPORATION)
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- HOLOGIC, INC.
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- MDXHEALTHCARE
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- Myraid genetics, inc.
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- Prostatype Genomics
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- PROTEOMEDIX
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- questionnaire
- related reports
表のリスト
TABLE 1 AGE AND PROBABILITY OF DEVELOPING PROSTATE CANCER
TABLE 2 Europe prostate cancer diagnostics market, By product type, 2019-2028 (USD Million)
TABLE 3 Europe prostate cancer diagnostics market, By product type, 2019-2028 (UNits)
TABLE 4 Europe prostate cancer diagnostics market, By DIAGNOSTICS TYPE, 2019-2028 (USD Million)
TABLE 5 EUROPE preliminary screening tests IN PROSTATE CANCER DIAGNOSTICS MARKET, By DIAGNOSTICS TYPE, 2019-2028 (USD million)
TABLE 6 EUROPE Confirmatory tests IN PROSTATE CANCER DIAGNOSTICS MARKET, By DIAGNOSTICS TYPE, 2019-2028 (USD million)
TABLE 7 EUROPE imaging tests IN PROSTATE CANCER DIAGNOSTICS MARKET, By DIAGNOSTICS TYPE, 2019-2028 (USD million)
TABLE 8 EUROPE Magnetic Resonance Imaging (MRI) IN PROSTATE CANCER DIAGNOSTICS MARKET, By DIAGNOSTICS TYPE, 2019-2028 (USD million)
TABLE 9 EUROPE biomarker IN PROSTATE CANCER DIAGNOSTICS MARKET, By DIAGNOSTICS TYPE, 2019-2028 (USD million)
TABLE 10 Europe prostate cancer diagnostics market, By type, 2019-2028 (USD million)
TABLE 11 Europe prostate cancer diagnostics market, By age group, 2019-2028 (USD Million)
TABLE 12 Europe prostate cancer diagnostics market, By Stage, 2019-2028 (USD Million)
TABLE 13 Europe prostate cancer diagnostics market, By Sample Type, 2019-2028 (USD Million)
TABLE 14 Europe prostate cancer diagnostics market, By End Users, 2019-2028 (USD Million)
TABLE 15 Europe prostate cancer diagnostics market, By distribution channel, 2019-2028 (USD Million)
TABLE 16 Europe prostate cancer diagnostics market, By country, 2019-2028 (USD Million)
TABLE 17 GERMANY Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)
TABLE 18 GERMANY Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)
TABLE 19 GERMANY Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 20 GERMANY Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 21 GERMANY Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 22 GERMANY Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 23 GERMANY Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 24 GERMANY Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 25 GERMANY Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)
TABLE 26 GERMANY Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)
TABLE 27 GERMANY Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)
TABLE 28 GERMANY Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)
TABLE 29 GERMANY Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)
TABLE 30 GERMANY Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 31 FRANCE Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)
TABLE 32 FRANCE Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)
TABLE 33 FRANCE Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 34 FRANCE Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 35 FRANCE Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 36 FRANCE Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 37 FRANCE Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 38 FRANCE Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 39 FRANCE Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)
TABLE 40 FRANCE Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)
TABLE 41 FRANCE Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)
TABLE 42 FRANCE Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)
TABLE 43 FRANCE Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)
TABLE 44 FRANCE Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 45 U.K. Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)
TABLE 46 U.K. Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)
TABLE 47 U.K. Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 48 U.K. Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 49 U.K. Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 50 U.K. Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 51 U.K. Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 52 U.K. Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 53 U.K. Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)
TABLE 54 U.K. Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)
TABLE 55 U.K. Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)
TABLE 56 U.K. Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)
TABLE 57 U.K. Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)
TABLE 58 U.K. Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 59 ITALY Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)
TABLE 60 ITALY Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)
TABLE 61 ITALY Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 62 ITALY Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 63 ITALY Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 64 ITALY Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 65 ITALY Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 66 ITALY Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 67 ITALY Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)
TABLE 68 ITALY Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)
TABLE 69 ITALY Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)
TABLE 70 ITALY Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)
TABLE 71 ITALY Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)
TABLE 72 ITALY Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 73 SPAIN Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)
TABLE 74 SPAIN Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)
TABLE 75 SPAIN Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 76 SPAIN Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 77 SPAIN Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 78 SPAIN Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 79 SPAIN Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 80 SPAIN Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 81 SPAIN Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)
TABLE 82 SPAIN Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)
TABLE 83 SPAIN Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)
TABLE 84 SPAIN Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)
TABLE 85 SPAIN Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)
TABLE 86 SPAIN Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 87 RUSSIA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)
TABLE 88 RUSSIA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)
TABLE 89 RUSSIA Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 90 RUSSIA Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 91 RUSSIA Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 92 RUSSIA Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 93 RUSSIA Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 94 RUSSIA Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 95 RUSSIA Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)
TABLE 96 RUSSIA Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)
TABLE 97 RUSSIA Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)
TABLE 98 RUSSIA Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)
TABLE 99 RUSSIA Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)
TABLE 100 RUSSIA Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 101 SWITZERLAND Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)
TABLE 102 SWITZERLAND Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)
TABLE 103 SWITZERLAND Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 104 SWITZERLAND Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 105 SWITZERLAND Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 106 SWITZERLAND Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 107 SWITZERLAND Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 108 SWITZERLAND Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 109 SWITZERLAND Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)
TABLE 110 SWITZERLAND Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)
TABLE 111 SWITZERLAND Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)
TABLE 112 SWITZERLAND Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)
TABLE 113 SWITZERLAND Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)
TABLE 114 SWITZERLAND Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 115 NETHERLANDS Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)
TABLE 116 NETHERLANDS Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)
TABLE 117 NETHERLANDS Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 118 NETHERLANDS Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 119 NETHERLANDS Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 120 NETHERLANDS Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 121 NETHERLANDS Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 122 NETHERLANDS Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 123 NETHERLANDS Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)
TABLE 124 NETHERLANDS Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)
TABLE 125 NETHERLANDS Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)
TABLE 126 NETHERLANDS Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)
TABLE 127 NETHERLANDS Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)
TABLE 128 NETHERLANDS Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 129 TURKEY Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)
TABLE 130 TURKEY Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)
TABLE 131 TURKEY Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 132 TURKEY Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 133 TURKEY Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 134 TURKEY Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 135 TURKEY Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 136 TURKEY Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 137 TURKEY Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)
TABLE 138 TURKEY Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)
TABLE 139 TURKEY Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)
TABLE 140 TURKEY Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)
TABLE 141 TURKEY Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)
TABLE 142 TURKEY Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 143 BELGIUM Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)
TABLE 144 BELGIUM Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)
TABLE 145 BELGIUM Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 146 BELGIUM Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 147 BELGIUM Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 148 BELGIUM Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 149 BELGIUM Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 150 BELGIUM Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 151 BELGIUM Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)
TABLE 152 BELGIUM Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)
TABLE 153 BELGIUM Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)
TABLE 154 BELGIUM Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)
TABLE 155 BELGIUM Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)
TABLE 156 BELGIUM Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 157 rest of Europe prostate cancer diagnostics market, By Product Type, 2019-2028 (USD Million)
図表一覧
FIGURE 1 EUROPE PROSTATE CANCER DIAGNOSTICS MARKET: segmentation
FIGURE 2 EUROPE PROSTATE CANCER DIAGNOSTICS MARKET: data triangulation
FIGURE 3 EUROPE PROSTATE CANCER DIAGNOSTICS MARKET: DROC ANALYSIS
FIGURE 4 EUROPE PROSTATE CANCER DIAGNOSTICS MARKET: regional VS country MARKET ANALYSIS
FIGURE 5 EUROPE PROSTATE CANCER DIAGNOSTICS MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 EUROPE PROSTATE CANCER DIAGNOSTICS MARKET: MULTIVARIATE MODELLING
FIGURE 7 EUROPE PROSTATE CANCER DIAGNOSTICS MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 8 EUROPE PROSTATE CANCER DIAGNOSTICS MARKET: DBMR MARKET POSITION GRID
FIGURE 9 EUROPE PROSTATE CANCER DIAGNOSTICS MARKET: MARKET end users coverage GRID
FIGURE 10 EUROPE PROSTATE CANCER DIAGNOSTICS MARKET: VENDOR SHARE ANALYSIS
FIGURE 11 EUROPE PROSTATE CANCER DIAGNOSTICS MARKET: SEGMENTATION
FIGURE 12 INCREASING PREVALENCE OF PROSTATE CANCER and INCREASED RESEARCH & DEVELOPMENT IN PROSTATE CANCER DIAGNOSTICs are DRIVing THE EUROPE PROSTATE CANCER DIAGNOSTICS MARKET IN THE FORECAST PERIOD OF 2021 to 2028
FIGURE 13 REAGENTS & CONSUMABLES segment is expected to account for the largest share of the EUROPE PROSTATE CANCER DIAGNOSTICS MARKETin 2021 & 2028
FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF EUROPE PROSTATE CANCER DIAGNOSTICS MARKET
FIGURE 15 GERIATRIC POPULATION IN THE EUROPEAN REGION
FIGURE 16 Europe prostate cancer diagnostics market : BY product type, 2020
FIGURE 17 Europe prostate cancer diagnostics market : BY product type, 2021-2028 (USD Million)
FIGURE 18 Europe prostate cancer diagnostics market : BY product type, CAGR (2021-2028)
FIGURE 19 PROSTATE CANCER DIAGNOSTICS market : BY product type, LIFELINE CURVE
FIGURE 20 Europe prostate cancer diagnostics market : BY DIAGNOSTICS TYPE, 2020
FIGURE 21 Europe prostate cancer diagnostics market : BY DIAGNOSTICS TYPE 2021-2028 (USD Million)
FIGURE 22 Europe prostate cancer diagnostics market : BY DIAGNOSTICS TYPE, CAGR (2021-2028)
FIGURE 23 Europe prostate cancer diagnostics market : BY DIAGNOSTICS TYPE, LIFELINE CURVE
FIGURE 24 Europe prostate cancer diagnostics market : By type, 2020
FIGURE 25 Europe prostate cancer diagnostics market : By type, 2021-2028 (USD Million)
FIGURE 26 Europe prostate cancer diagnostics market : By type, CAGR (2021-2028)
FIGURE 27 Europe prostate cancer diagnostics market : By type, LIFELINE CURVE
FIGURE 28 Europe prostate cancer diagnostics market : BY age group, 2020
FIGURE 29 Europe prostate cancer diagnostics market : BY age group, 2021-2028 (USD Million)
FIGURE 30 Europe prostate cancer diagnostics market : BY age group, CAGR (2021-2028)
FIGURE 31 Europe prostate cancer diagnostics market : BY age group, LIFELINE CURVE
FIGURE 32 Europe prostate cancer diagnostics market : BY stage, 2020
FIGURE 33 Europe prostate cancer diagnostics market : BY stage, 2021-2028 (USD Million)
FIGURE 34 Europe prostate cancer diagnostics market : BY stage, CAGR (2021-2028)
FIGURE 35 Europe prostate cancer diagnostics market : BY stage, LIFELINE CURVE
FIGURE 36 Europe prostate cancer diagnostics market : BY sample type, 2020
FIGURE 37 Europe prostate cancer diagnostics market : BY sample type, 2021-2028 (USD Million)
FIGURE 38 Europe prostate cancer diagnostics market : BY sample type, CAGR (2021-2028)
FIGURE 39 Europe prostate cancer diagnostics market : BY sample type, LIFELINE CURVE
FIGURE 40 Europe prostate cancer diagnostics market : BY end users, 2020
FIGURE 41 Europe prostate cancer diagnostics market : BY end users, 2021-2028 (USD Million)
FIGURE 42 Europe prostate cancer diagnostics market : BY end users, CAGR (2021-2028)
FIGURE 43 Europe prostate cancer diagnostics market : BY end users, LIFELINE CURVE
FIGURE 44 Europe prostate cancer diagnostics market : BY distribution channel, 2020
FIGURE 45 Europe prostate cancer diagnostics market : BY distribution channel, 2021-2028 (USD Million)
FIGURE 46 Europe prostate cancer diagnostics market : BY distribution channel, CAGR (2021-2028)
FIGURE 47 Europe prostate cancer diagnostics market : BY distribution, LIFELINE CURVE
FIGURE 48 Europe prostate cancer diagnostics market : SNAPSHOT (2020)
FIGURE 49 Europe prostate cancer diagnostics market : BY COUNTRY (2020)
FIGURE 50 Europe prostate cancer diagnostics market : BY COUNTRY (2021 & 2028)
FIGURE 51 Europe prostate cancer diagnostics market : BY COUNTRY (2020 & 2028)
FIGURE 52 Europe prostate cancer diagnostics market : BY Product type (2021-2028)
FIGURE 53 europe Prostate cancer diagnostics market: company share 2020 (%)
調査方法
データ収集と基準年分析は、大規模なサンプル サイズのデータ収集モジュールを使用して行われます。この段階では、さまざまなソースと戦略を通じて市場情報または関連データを取得します。過去に取得したすべてのデータを事前に調査および計画することも含まれます。また、さまざまな情報ソース間で見られる情報の不一致の調査も含まれます。市場データは、市場統計モデルと一貫性モデルを使用して分析および推定されます。また、市場シェア分析と主要トレンド分析は、市場レポートの主要な成功要因です。詳細については、アナリストへの電話をリクエストするか、お問い合わせをドロップダウンしてください。
DBMR 調査チームが使用する主要な調査方法は、データ マイニング、データ変数が市場に与える影響の分析、および一次 (業界の専門家) 検証を含むデータ三角測量です。データ モデルには、ベンダー ポジショニング グリッド、市場タイムライン分析、市場概要とガイド、企業ポジショニング グリッド、特許分析、価格分析、企業市場シェア分析、測定基準、グローバルと地域、ベンダー シェア分析が含まれます。調査方法について詳しくは、お問い合わせフォームから当社の業界専門家にご相談ください。
カスタマイズ可能
Data Bridge Market Research は、高度な形成的調査のリーダーです。当社は、既存および新規のお客様に、お客様の目標に合致し、それに適したデータと分析を提供することに誇りを持っています。レポートは、対象ブランドの価格動向分析、追加国の市場理解 (国のリストをお問い合わせください)、臨床試験結果データ、文献レビュー、リファービッシュ市場および製品ベース分析を含めるようにカスタマイズできます。対象競合他社の市場分析は、技術ベースの分析から市場ポートフォリオ戦略まで分析できます。必要な競合他社のデータを、必要な形式とデータ スタイルでいくつでも追加できます。当社のアナリスト チームは、粗い生の Excel ファイル ピボット テーブル (ファクト ブック) でデータを提供したり、レポートで利用可能なデータ セットからプレゼンテーションを作成するお手伝いをしたりすることもできます。
